FR2232315A1 - - Google Patents

Info

Publication number
FR2232315A1
FR2232315A1 FR7420201A FR7420201A FR2232315A1 FR 2232315 A1 FR2232315 A1 FR 2232315A1 FR 7420201 A FR7420201 A FR 7420201A FR 7420201 A FR7420201 A FR 7420201A FR 2232315 A1 FR2232315 A1 FR 2232315A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7420201A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2232315A1 publication Critical patent/FR2232315A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7420201A 1973-06-11 1974-06-11 Withdrawn FR2232315A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US369044A US3907822A (en) 1973-06-11 1973-06-11 Anti-inflammatory (2-benzimidazoylthio)alkylamidoximes

Publications (1)

Publication Number Publication Date
FR2232315A1 true FR2232315A1 (fr) 1975-01-03

Family

ID=23453848

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7420201A Withdrawn FR2232315A1 (fr) 1973-06-11 1974-06-11

Country Status (5)

Country Link
US (1) US3907822A (fr)
JP (1) JPS5035162A (fr)
AU (1) AU6964374A (fr)
DE (1) DE2428061A1 (fr)
FR (1) FR2232315A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274867A2 (fr) * 1986-12-10 1988-07-20 Schering Corporation Composés pharmaceutiques actifs
EP0334818A1 (fr) * 1988-03-25 1989-09-27 DOMPE' FARMACEUTICI S.p.A. Dérivés d'alkylthiobenzimidazole ayant une activité pharmacoligique et procédé de leur préparation
EP0407217A1 (fr) * 1989-07-07 1991-01-09 Schering Corporation Composés d'une activité pharmaceutique

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230865A (en) * 1971-03-09 1980-10-28 Smith Kline & French Laboratories Limited Pharmacologically active triazole and thiadiazole thiourea and urea compounds
US4287198A (en) * 1971-03-09 1981-09-01 Smith Kline & French Laboratories Limited Pharmacologically active guanidine compounds
US4221802A (en) * 1972-02-03 1980-09-09 Smith Kline & French Laboratories Limited Pharmacologically active guanidine compounds for inhibiting H-2 histamine receptors
US4335132A (en) * 1980-12-29 1982-06-15 Sterling Drug, Inc. 5-(Py-Y)-1H-benzimidazol-2-ols and 5-(Py-Y-)-1H-benzimidazole-2-thiols
JPS60139943U (ja) * 1984-02-28 1985-09-17 株式会社小松製作所 ダンパ装置
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7303M (fr) * 1967-03-07 1969-09-29
DE1670497C3 (de) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274867A2 (fr) * 1986-12-10 1988-07-20 Schering Corporation Composés pharmaceutiques actifs
EP0274867A3 (en) * 1986-12-10 1990-11-14 Schering Corporation Pharmaceutically active compounds
EP0334818A1 (fr) * 1988-03-25 1989-09-27 DOMPE' FARMACEUTICI S.p.A. Dérivés d'alkylthiobenzimidazole ayant une activité pharmacoligique et procédé de leur préparation
EP0407217A1 (fr) * 1989-07-07 1991-01-09 Schering Corporation Composés d'une activité pharmaceutique
WO1991000858A1 (fr) * 1989-07-07 1991-01-24 Schering Corporation Composes pharmaceutiquement actifs

Also Published As

Publication number Publication date
US3907822A (en) 1975-09-23
AU6964374A (en) 1975-12-04
DE2428061A1 (de) 1975-01-02
JPS5035162A (fr) 1975-04-03

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
FR2232315A1 (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU477823B2 (fr)
AU461342B2 (fr)
AR195948A1 (fr)
AR196382A1 (fr)
AR201432A1 (fr)
AU471461B2 (fr)
AU447540B2 (fr)
AR210729A1 (fr)
AU477824B2 (fr)
AR195311A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse